Moffat's results are irrelevant for NNVC shareholders.
That's because NNVC has no rights for a shingles indication.
Diwan, on the other hand, will benefit greatly if the results are positive!
More money for Theracour!
All paid for courtesy of NNVC's shareholders, and handed on a platter to the Diwan estate!
Zero-risk for Diwan, since Seymour in his generosity on behalf of NNVC investors, is paying for it all!